• Home
  • About
    • Our Constitution
    • Chairman’s words
    • Chairman and Board Members
  • Members
    • Become a Member
  • Annual Meetings
    • 1st Annual Meeting – 2010
    • 2nd Annual Meeting – 2011
    • 3rd Annual Meeting – 2012
    • 4th Annual Meeting -2013
    • 5th Annual Meeting- 2014
    • 7th Annual Meeting -2016
    • 8th Annual Meeting -2017
    • 9th Annual Meeting -2018
    • 10th Annual Meeting
    • 11th Annual Meeting
    • 12th Annual Meeting
  • Abstracts
    • Abstracts 2010
    • Abstracts 2011
    • Abstracts 2012
    • Abstracts 2014
    • Abstracts 2015
    • Abstracts 2016
    • Abstracts 2017
    • Abstracts 2018
    • Full Abstract List
  • Organizations
    • ISMFM
    • Israel Medical Association
    • Placenta – The Official Jourmal of IFPA
    • The Israel Fertility Association
    • SMFM
    • International Federation of Placenta Associations
    • The Endocrine Society of Australia
    • Nano Science
    • The Society for Reproductive Biology
    • Australasian Diabetes in Pregnancy Society
    • Society of Theriogenology
    • American College of Theriogenologists
    • The Fetal Medicine Foundation
  • Contact
Menu
  • Home
  • About
    • Our Constitution
    • Chairman’s words
    • Chairman and Board Members
  • Members
    • Become a Member
  • Annual Meetings
    • 1st Annual Meeting – 2010
    • 2nd Annual Meeting – 2011
    • 3rd Annual Meeting – 2012
    • 4th Annual Meeting -2013
    • 5th Annual Meeting- 2014
    • 7th Annual Meeting -2016
    • 8th Annual Meeting -2017
    • 9th Annual Meeting -2018
    • 10th Annual Meeting
    • 11th Annual Meeting
    • 12th Annual Meeting
  • Abstracts
    • Abstracts 2010
    • Abstracts 2011
    • Abstracts 2012
    • Abstracts 2014
    • Abstracts 2015
    • Abstracts 2016
    • Abstracts 2017
    • Abstracts 2018
    • Full Abstract List
  • Organizations
    • ISMFM
    • Israel Medical Association
    • Placenta – The Official Jourmal of IFPA
    • The Israel Fertility Association
    • SMFM
    • International Federation of Placenta Associations
    • The Endocrine Society of Australia
    • Nano Science
    • The Society for Reproductive Biology
    • Australasian Diabetes in Pregnancy Society
    • Society of Theriogenology
    • American College of Theriogenologists
    • The Fetal Medicine Foundation
  • Contact
Facebook
Defining The Role Of Alternative Splicing In Trophoblast Differentiation: Implication For Maternal And Fetal Health
Home ‹ 2015 Abstracts ‹ Defining The Role Of Alternative Splicing In Trophoblast Differentiation: Implication For Maternal And Fetal Health

Debra Goldman-Wohl, PhD1, Caryn Greenfield, MSc1, Iris Eisenberg, PhD1, Galia Skarzinsky, PhD2, Tal Imbar, MD1, Ronit Haimov-Kochman, MD1, Polina Denichenko, PhD3, Rotem Karni, PhD3, Ilana Ariel, MD, PhD2 , Sandra Blois, MD4 and Simcha Yagel, MD1.

1Magda and Richard Hoffman Center for Placenta Research, Obstetrics and Gynecology, 2Pathology, 3Biochemistry and Molecular Biology, IMRIC, Hebrew University-Hadassah Medical School, Jerusalem, Israel. 4Universitätsmedizin Charité, Berlin, Germany

Introduction: The progenitor cytotrophoblast of the human placenta can differentiate by fusion to the syncytiotrophoblast or to the invasive extravillous trophoblast. Rbfox2, an RNA-binding protein, controls tissue-specific alternative splicing in diverse processes such as epithelial to mesenchyme transition and myoblast cell fusion. The placenta represents a singular system where two diverse activities of Rbfox2 regulation, cell invasion and cell fusion, may be studied.   Our preliminary results suggest that Rbfox2, by conferring mRNA diversity, may act as a master regulator in trophoblast differentiation to either the fusion or invasive pathways.  In this investigation we characterize the contribution of Rbfox2 to trophoblast differentiation in both mouse and human placenta.
Materials and Methods: Rbfox2 immunohistochemistry/immunofluorescence was performed on human and murine placental tissue sections in normal pregnancy and in placental pathologies.  Inhibition of Rbfox2 alternative splicing in isolated primary trophoblasts was evaluated by immunofluorescence and BhCG.

Results: Trophoblast lineage specific expression of Rbfox2 was observed in both normal and pathological human placentas. Rbfox2 is expressed in the progenitor cytotrophoblast, reduced in the terminally differentiated syncytiotrophoblast and conversely, highly expressed in an increasing gradient of expression in the invasive trophoblasts. Reduced Rbfox2 expression was observed in fused primary trophoblast cell culture with inhibition of Rbfox2 upregulating BhCG production. Murine Rbfox2 expression changes as gestation progresses.  As compared to normal pregnancy, decreased staining was observed in a spontaneous abortion prone model, and more intense staining observed in a preeclampsia model.

Conclusions: Rbfox2, an alternative splicing factor, is differentially expressed in specific trophoblast cell lineages and may act as the molecular switch determining the trophoblast differentiation pathway with implications to several human pregnancy disorders including preeclampsia, fetal growth restriction, and preterm labor.

« Previous
Next »
Powered by Netmii and Art + Web
All rights reserved to ISPR -Israel Society for Placental Research
Scroll to top